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Abstract
Objective: Earlier studies in Europeans have identified small dense LDL to be associated with coronary artery
disease and diabetes. In this study we assessed the association of small dense LDL with diabetes and CAD in
Asian Indians.
Methods: Study subjects were selected from the Chennai Urban Rural Epidemiology Study (CURES), a
population based study on representative sample of Chennai city in southern India. Group 1:non-diabetic
subjects (n=30); Group 2: diabetic subjects without CAD (n=30); Group 3:diabetic subjects with CAD (n=30).
LDL subfractions were estimated using LipoPrint LDL system. LDL subfractions 3 and above, defined as
small dense LDL was summed up to determine the overall small LDL. 75th percentile of the overall small
dense LDL in non-diabetic subjects was used as a cut-off for defining elevated levels of small dense LDL.
Results: The mean age of the study subjects was not significantly different among groups.  Overall small
dense LDL was significantly higher in diabetic subjects with CAD      (16.7 ± 11.1 mg/dl, p<0.05) and without
CAD (11.1 ± 8.0 mg/dl, p<0.05) compared to non-diabetic subjects without CAD (7.2 ± 6.8 mg/dl). Small
dense LDL showed a positive correlation with fasting plasma glucose (r=0.252, p=0.023), HbA1c (r=0.281,
p=0.012), total cholesterol (r=0.443, p<0.001), triglycerides(r=0.685, p<0.001), LDL(r=0.342, p=0.002), total
cholesterol/HDL ratio (r=0.660, p=<0.001) and triglycerides/HDL ratio(r=0.728, p<0.001) and a negative
correlation with HDL cholesterol (r= -0.341, p=0.002) and QUICKI values (r= -0.260, p=0.019). ROC curves
constructed to predict elevated small dense LDL ((9.0 mg/dl) revealed that triglycerides/HDL ratio and total
cholesterol/HDL ratio had higher AUC values compared to other parameters.  A triglycerides/HDL ratio of
3.0 had the optimum sensitivity (80.0%) and specificity (78.0%) for detecting elevated small dense LDL.
Conclusion: This data suggests that in Asian Indians, small dense LDL is associated with both diabetes and
CAD and that a triglycerides/HDL ratio (3.0 could serve a surrogate marker of small dense LDL. ©
higher frequency of small dense LDL in Indians4 while
the other reported that Indians have larger LDL size.5
However, both these studies merely looked at the
frequency of LDL subfractions in Indians and not
specifically at its association with CAD.4,5 Further,
migrant Indians differ from native Indians in being more
affluent and consequently they have higher BMI, waist
circumference and increased triglycerides levels.6 There
are no studies to our knowledge on small dense LDL in
native Indians.
Earlier studies have shown small dense LDL levels to
be increased in diabetic compared to non-diabetic
subjects.7,8 India has the largest number of diabetic
subjects in the world.9 Moreover Asian Indians have
been shown to have a greater degree of insulin resistance3
and insulin resistance is associated with small dense
LDL. Hence we felt it was useful to look at the association
of small dense LDL with diabetes and coronary artery
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Asian Indians have been consistently shown to havehigher prevalence of premature coronary artery
disease compared to Europeans (CAD).1 Within the
Indian subcontinent, the prevalence of CAD has
increased by a factor of 10 within the last 40 years.2 It
has been reported that migrant Asian Indians have a
typical dyslipidemia characterized by high triglycerides
and low HDL levels with near normal LDL cholesterol
levels.3 However recent studies suggest that LDL
cholesterol levels are strongly linked to coronary artery
disease in Indians within the subcontinent.2
Two earlier studies4,5 have compared small dense LDL
distribution in migrant Indians and Europeans, but these
produced contradictory results with one showing a
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disease in a native Indian population and this was the
basis of the present study.
MATERIALS AND METHODS
Sample selection: The Chennai Urban Rural
Epidemiology Study (CURES) is an ongoing
epidemiological study conducted on a representative
population (aged ≥ 20 years) of Chennai (formerly
Madras) the fourth largest city in India with a population
of about 4.2 million. The methodology of the study has
been published elsewhere.10 Briefly, in Phase 1 of the
urban component of CURES, 26,001 individuals were
recruited based on a systematic random sampling
technique. Self reported diabetic subjects were classified
as ‘known diabetic subjects’.  In Phase 2 of CURES, all
known diabetic subjects (n=1529) were invited to our
centre for detailed studies on vascular complications. In
addition, age and sex matched non-diabetic subjects
underwent oral glucose tolerance tests (OGTT) using 75
grams of glucose load. Those who were confirmed by
OGTT to have fasting plasma glucose < 110mg/dl and 2
hr plasma glucose value <140 mg/dl were categorized
as normal glucose tolerance (NGT).11 For known diabetic
subjects fasting and postprandial plasma glucose after
a standard breakfast was measured.  All study subjects
underwent a 12 lead ECG.
The following groups of subjects were randomly
selected from CURES for this study.
Group 1 comprised of 30 selected healthy non-diabetic
subjects without CAD. The inclusion criteria for this
group were normal glucose tolerance, non-smokers with
normal resting 12 lead ECG and absence of history of
angina or myocardial infarction.
Group 2 consisted of 30 Type 2 diabetic patients
without CAD. Diabetes was defined according to WHO
consulting group criteria, but the other inclusion criteria
were similar to Group 1.
Group 3 consisted of 30 Type 2 diabetic patients as
defined above but additionally had CAD. CAD was
diagnosed based on a past history of documented
myocardial infarction and /or medical therapy (nitrates)
or revascularization for CAD and/or
electrocardiographic (ECG) changes suggestive of Q
wave changes (Minnesota codes 1-1-1 to 1-1-7) and/or
ST segment depression (Minnesota codes 4-1 to 4-2).
Institutional ethical committee approval was obtained
for the study and informed consent was obtained from
all study subjects.
Anthropometric measurements
Physical examination included height and weight
measurements and the body mass index (BMI) was
calculated.  Waist measurements were done in the
standing position as described elsewhere.10 Blood
pressure (BP) was recorded to the nearest 2 mmHg in
the sitting position in the right arm with a mercury
sphygmomanometer (Diamond Deluxe BP apparatus,
Industrial Electronic and allied products, Electronic Co-
op Estate, Pune, India).  Two readings were taken 5
minutes apart and the mean of the two was calculated.
Biochemical parameters
Biochemical analyses were done on Hitachi - 912
Autoanalyser (Hitachi, Mannheim, Germany) using kits
supplied by Roche Diagnostics, (Mannheim, Germany).
Fasting plasma glucose (GOD - POD method), serum
cholesterol (CHOD-PAP method), serum triglycerides
(GPO-PAP method) and HDL cholesterol (direct method
- polyethylene glycol-pretreated enzymes) were
measured. Low-density lipoprotein (LDL) cholesterol
was calculated using the Friedewald formula.12 Glycated
hemoglobin (HbA1C) was estimated by high-
performance liquid chromatography using the Variant
machine (Bio-Rad, Hercules, Calif., USA).  Serum insulin
concentration was estimated using Dako kits (Dako,
Glostrup, Denmark). Insulin sensitivity was calculated
using the QUICKI formula: QUICKI = 1/[(log (I0) + log
(G0)], where I0 is the fasting plasma insulin level (µIU/
ml), and G0 is the fasting plasma glucose level (mg/dl).
13
Estimation of small dense LDL
Small dense LDL was determined using
electrophoresis with high-resolution 3% poly-
acrylamide tube gel with LipoPrint LDL System
(Quantimetrix Corp., Redondo Beach, CA, USA).
LipoPrint LDL system was approved by US FDA and
uses polyacrylamide gel electrophoresis for separation
of LDL subfractions.  In brief, 25 µl of sample mixed with
200 µl of LipoPrint loading gel, was loaded on 3%
polyacrylamide gel. Lipid specific dye was used to stain
the lipoproteins. After 30 minutes of photo-
polymerization at room temperature, electrophoresis was
done for 60 minutes.  The gel tubes were scanned after
30 minutes of completion of electrophoresis. For
quantification, scanning was done at 610 nm with
Artixscan 1100 scanner (Microtek Co., USA) and iMac
personal computer (Apple Computer Inc., USA). After
scanning, electrophoretic mobility (Rf) and area under
the curve (AUC) were analyzed quantitatively with NIH
image program vs. 1.62 (US National Institute of Health,
USA). LDL subfractions were calculated with Rf between
VLDL fraction, whose Rf was 0.0 and HDL fraction,
whose Rf was 1.0. LDL is distributed from Rf 0.30 to Rf
0.61 as 7 bands, whose Rf’s are 0.30, 0.36, 0.41, 0.46,
0.51, 058, and 0.61 and they are termed as LDL 1 to LDL
7. LDL 1 and LDL 2 are defined as the large LDL and
LDL 3 and above as small LDL.7 The subfractions of
lipoprotein were expressed as mg/dl.
Six samples were repeated for determining the
reproducibility of the assay. The intra-assay co-efficient
of variation (CV) ranged from 1.6% to 4.2% for the LDL
subfractions, while the interassay CV ranged from 2.5%
to 4.9%.
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STATISTICAL ANALYSIS
LDL subfractions 3 and above, representing small
sized LDL were summed up to determine the overall
small dense LDL fraction. One-way ANOVA or students
“t” test as appropriate was used to compare groups for
continuous variables. Mann-Whitney U or Kruskal-
Wallis H test as appropriate was used for comparisons
between groups for the parameters, which showed
significance for normality with Kolmogorov- Smirnov
test.
Chi-square test or Fisher’s Exact test as appropriate
was used to compare proportions. Spearman’s
correlation analysis was done to determine the relation
of small dense LDL with other risk variables. Univariate
regression analysis was done to determine the
association of small dense LDL with diabetes and CAD.
75th percentile of the overall small dense LDL fractions
in the non-diabetic group was taken as a cut-off for
defining elevated small dense LDL. Receiver Operating
Characteristic (ROC) Curve was constructed for
diagnosis of small dense LDL with various lipid
parameters. Cut-off values were selected based on
optimum sensitivity and specificity. All analysis was
done using Windows based SPSS statistical package
(Version 10.0, Chicago) and p values <0.05 were taken
as the level of significance.
RESULTS
Table 1 shows the clinical characteristics of the study
groups. HbA1c (p < 0.001), serum cholesterol (p<0.01),
serum triglycerides (p<0.01), LDL (p<0.05), total
cholesterol/HDL ratio (p<0.05) and triglycerides / HDL
ratio (p<0.01) were significantly higher in diabetic
subjects with CAD compared to non-diabetic subjects.
QUICKI (p < 0.001) was significantly lower in diabetic
subjects with CAD compared to non-diabetic subjects.
There was no difference in the anti-diabetic therapy
between subjects with and without CAD (Diabetic
subjects with CAD: 4 (13%) on diet alone, 21 (70%) on
oral hypoglycemic drugs (OHA), 3 (10%) on insulin and
2 (7%) on a combination of insulin and OHA, Diabetic
subjects without CAD: 3 (10%) on diet alone, 20 (67%) on
oral hypoglycemic drugs (OHA), 3 (10%) on insulin and
4 (13%) on a combination of insulin and OHA). None of
the study subjects were on statin or aspirin therapy.
LDL subfraction 3 was significantly higher in diabetic
subjects with CAD compared to non-diabetic subjects
(12.2 ± 9.6 vs 6.4 ± 6.6 mg/dl, p < 0.05), while LDL
subfraction 4 was significantly higher in diabetic subjects
with CAD compared to both healthy normals (p<0.05)
and diabetic subjects without CAD (p<0.05) (normal:
0.7 ± 0.4 mg/dl, diabetes without CAD: 1.5 ± 2.1 mg/dl,
diabetes with CAD: 3.7 ± 4.9 mg/dl).  LDL subfraction 5
was also significantly higher in diabetic subjects with
CAD compared to both healthy normals (p<0.05) and
diabetic subjects without CAD (p<0.05) (normal: 0.07 ±
0.39 mg/dl, diabetes without CAD: 0.06 ± 0.34 mg/dl,
diabetes with CAD: 0.79 ± 1.27 mg/dl). Overall small
dense LDL fraction (LDL fractions 3 and above) was
significantly higher in diabetic subjects with CAD
(p<0.001) and without CAD (p<0.05) compared to
healthy normals (Table 2).
The 75th percentile of the overall small dense LDL
fractions in the non-diabetic group was 9.0 mg/dl.
Using this cut off, the proportion of subjects with elevated
small dense LDL in the study groups was computed.
58% of the diabetic subjects with CAD and 51% of the
diabetic subjects without CAD had elevated levels of
small dense LDL.
Small dense LDL showed a positive correlation with
Table 1 : Clinical and biochemical characterstics of study groups
Variables Non-diabetic subjects Type 2 diabetic Type 2 diabetic
without CAD without CAD with CAD
(n=30) (n=30) (n=30)
Age (Yrs) 56 ± 11 57 ± 10 57 ± 8
Males n (%) 15(50) 15(50) 15(50)
Duration of diabetes (Yrs) — 6 ± 6 9 ± 7
Body mass index (Kg/m2) 23.0 ± 5.4 24.9 ± 4.4 23.8 ± 3.1
Waist circumference (cms) 87 ± 16 92 ± 12 94 ± 13
Systolic BP (mm/Hg) 125 ± 14 133 ± 22 135 ± 28
Diastolic BP (mm/Hg) 78 ± 11 76 ± 9 79 ± 13
Fasting plasma glucose (mg/dl) 85 ± 7 167 ± 56 *** 171 ± 61 ***
HbA1c (%) 5.7 ± 0.6 8.7 ± 1.8 *** 9.6 ± 2.2 ***
Total cholesterol (mg/dl) 180 ± 31 200 ± 39* 215 ± 46 **
Triglycerides (mg/dl) 106 ± 27 159 ± 80** 177 ± 97 **
HDL cholesterol (mg/dl) 46 ± 12 42 ± 8 42 ± 8
LDL cholesterol (mg/dl) 115 ± 31 123 ± 35 139 ± 39*
Cholesterol/HDL ratio 4.2 ± 1.1 4.5 ± 1.0 5.2 ± 1.4 ** #
Triglycerides /HDL ratio 2.6 ± 1.3 3.6 ± 2.1*  4.3 ± 2.3 **
QUICKI 0.36 ± 0.04 0.32 ± 0.03 *** 0.32 ± 0.04 ***
* p<0.05, ** p<0.01, *** p<0.001 compared to non-diabetic subjects without CAD, # p<0.05 compared to diabetic subjects without
CAD
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fasting plasma glucose (p=0.023), HbA1c (p=0.012), total
cholesterol (p<0.001), triglycerides (p<0.001), LDL
(p=0.002) and total cholesterol/HDL ratio (p=<0.001)
and triglycerides/HDL ratio (p<0.001) and a negative
correlation with HDL cholesterol (p=0.002) and QUICKI
values (p=0.019). The highest correlation was found with
triglycerides / HDL ratio (r=0.728) (Table 3).
The proportion of subjects with elevated small dense
LDL was computed according to different tertiles of
triglycerides/HDL ratio. 3.3% of the study subjects in
the first tertile, 40.0% in the second tertile, and 90.0% in
the third tertile had small dense LDL (trend chi square -
45.6, p<0.001).
Receiver Operating Characteristic (ROC) curve were
constructed for predicting elevated small dense LDL
using various lipid parameters. The area under the curve
(AUC) for each lipid parameter is presented in Table 4.
Triglycerides /HDL ratio and total cholesterol/HDL
ratio had higher AUC values compared to other
parameters.  Total cholesterol/HDL ratio of 4.4 had the
optimum sensitivity (77.0%) and specificity (78.0%) for
detecting small dense LDL. The positive predictive value
for total cholesterol/HDL ratio of 4.4 was 74% and
negative predictive value was 81%. A triglycerides /
HDL ratio of 3.0 had the optimum sensitivity (80.0%)
and specificity (78.0%) for detecting elevated small dense
LDL while the positive predictive value was 74% and
negative predictive value, 83%.
Linear regression analysis was done to determine the
association of triglycerides/HDL ratio and cholesterol/
HDL with small dense LDL (Table 5). Even after adding
HbA1c and QUICKI into the regression equation, the
association of triglycerides/HDL ratio with small dense
LDL persisted (p<0.001).  Similarly total cholesterol/
HDL ratio also showed a good association with small
dense LDL even after adding HbA1c and QUICKI into
the regression equation (p < 0.001).
DISCUSSION
This study makes three important findings. First,
small dense LDL has a strong association with CAD
and diabetes in Asian Indians. Secondly, it shows a
positive correlation with HbA1c and a negative
correlation with insulin sensitivity (QUICKI) and HDL
cholesterol. Finally, small dense LDL shows a strong
Table 2 : Lipoprotein levels measured using lipoprint machine in the study groups
Variables Non-diabetic subjects Type 2 diabetic Type 2 diabetic
without CAD without CAD with CAD
(n=30) (n=30) (n=30)
Small dense LDL fraction 3 (mg/dl) 6.4 ± 6.6 9.6 ± 7.2* 12.2 ± 9.6 *
Small dense LDL fraction 4 (mg/dl) 0.7 ± 0.4 1.5 ± 2.1 3.7 ± 4.9 * #
Small dense LDL fraction 5 (mg/dl) 0.07 ± 0.39 0.06 ± 0.34 0.79 ± 1.27 * #
Overall small dense LDL (mg/dl) 7.2 ± 6.8 11.1 ± 8.0* 16.7 ± 11.1*#
* p<0.05 compared to non-diabetic subjects without CAD
# p<0.05 compared to type 2 diabetes without CAD
Table 3 : Correlation analysis of small dense LDL with
other risk variables
Variables Small dense LDL
r value p value
Age 0.010 0.378
Body mass index 0.086 0.378
Systolic BP 0.124 0.270
Diastolic BP 0.110 0.330
Waist 0.033 0.785
Fasting plasma glucose 0.252 0.023
HbA1c 0.281 0.012
QUICKI - 0.260 0.019
Total cholesterol 0.443 <0.001
Triglycerides 0.685 <0.001
HDL cholesterol -0.341 0.002
LDL cholesterol 0.342 0.002
Total cholesterol/HDL ratio 0.660 <0.001
Triglycerides/HDL ratio 0.728 <0.001
Table 4 : Area under the curve (AUC) for ROC’s to
determine the presence of small dense LDL
Variables Area
Triglycerides /HDL ratio 0.885
Total cholesterol/HDL ratio 0.857
Serum triglycerides 0.868
Total cholesterol 0.732
HDL- cholesterol 0.672
Table 5 : Linear regression analysis using small dense
LDL as a dependent variable
Variables Beta p value
Unadjusted
Triglycerides/HDL ratio 0.676 < 0.001
Adjusted for HbA1c
Triglycerides/HDL ratio 0.624 0.185
HbA1c  < 0.001 0.033
Adjusted for HbA1c and QUICKI
Triglycerides/HDL ratio 0.618 < 0.001
HbA1c 0.160 0.104
QUICKI - 0.052 0.590
Unadjusted
Total cholesterol/HDL ratio 0.636 < 0.001
Adjusted for HbA1c
Total cholesterol/HDL ratio 0.586 < 0.001
HbA1c 0.163 0.077
Adjusted for HbA1c and QUICKI
Total cholesterol/HDL ratio 0.579 < 0.001
HbA1c 0.129 0.213
QUICKI - 0.070 0.489
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association with triglycerides / HDL ratio and a value
of 3.0 had the optimum sensitivity and specificity to detect
elevated small dense LDL.
The pattern of LDL subfraction change with diseases
and subjects with diabetes7,8 and CAD have been shown
to have higher levels of small dense LDL fractions.4
Indeed prospective studies have shown small dense LDL
to be a predictor of both diabetes and CAD.14,15 The link
of small dense LDL to diabetes is considered to be through
insulin resistance.15,16 In our study, small dense LDL
showed a negative correlation with QUICKI, an
indication of decreased insulin sensitivity.  This result
corroborates earlier studies, which have shown insulin
resistance and plasma insulin levels to be associated
with small dense LDL.16
Small dense LDL is considered to be an atherogenic
moiety. While LDL cholesterol is a strong risk factor for
CAD, more than 50% of the subjects with CAD have
normal LDL cholesterol levels.17 The increased
prevalence of CAD among subjects with normal LDL
can be explained by LDL particle size. Studies have
shown small dense LDL to be more prone to oxidation
and conformational changes.18 This results in the
reduction of LDL clearance by its receptors, with
increased production of scavengers, which triggers
immunological changes resulting in atherosclerosis.   An
atherogenic lipoprotein pattern characterized by a
predominance of small dense LDL, moderately elevated
plasma triglycerides and low HDL levels, is the most
powerful risk factor for CAD.19 Thus the role of small
dense LDL as an important cardiovascular risk factor is
very well established among Europeans. In this we
confirm that even in Asian Indians who have one of the
highest prevalence rates of premature CAD, small dense
LDL is an important risk factor for CAD.
However, estimating small dense LDL still remains a
challenge, as methods such as ( quantification, nuclear
magnetic resonance or use of non-denaturing
polyacrylamide gel electrophoresis methods are
required. Moreover all these procedures are time-
consuming, labor intensive and expensive and these
factors restrict the use of small dense LDL as a
cardiovascular marker. In this context, an easy clinical
tool to determine the elevated small dense LDL would
be of great significance.
One of the interesting observations in this study is
that small dense LDL showed a strong correlation with
total triglycerides /HDL ratio and cholesterol/HDL ratio.
Although both total cholesterol/HDL ratio and
triglycerides/HDL ratio had a more or less same AUC
in the ROC, triglycerides / HDL ratio value of 3.0 had
the optimum sensitivity and specificity to predict
elevated small dense LDL. Surprisingly, this ratio is not
often used in clinical settings. An earlier study by
Maruyama et al20 showed that 75% of subjects with small
dense LDL had triglycerides / HDL ratio above 2.0. A
very recent editorial on atherogenic index of plasma
suggest the practical usefulness of log transformed
triglycerides/HDL ratio.21 In this study both
triglycerides/HDL ratio and their log-transformed
values had similar AUC for elevated small dense LDL
suggesting that both parameters could be used as
surrogates for elevated small dense LDL.  As routine
estimation of small dense LDL is difficult and expensive,
triglycerides/HDL ratio could be used as a surrogate
marker for small dense LDL for epidemiology studies.
In conclusion, our study shows that small dense LDL
is associated with both diabetes and CAD in Asian
Indians and that a triglycerides/HDL ratio ≥ 3.0 could
serve a surrogate marker of small dense LDL in this ethnic
group.
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